The FDA granted full approval of Pfizer's vaccine last August.Public health advocates initially hoped the regulatory distinction would boost public confidence in the shots. Vaccinations peaked last spring at more than 3 million per day, and now average less than 750,000 per day. Most cases are mild and resolve quickly.SEE MORE: Moderna Developing Combined Influenza, COVID-19 VaccineAdditionally, the FDA reviewed the company's manufacturing process and facilities. It is the first FDA-approved product for the Cambridge, Massachusetts-based company.In the U.S., the Moderna vaccination is used only for adults, both for initial vaccination and as a half-dose booster. The company said last fall that the FDA had delayed deciding whether to clear the shots for 12- to 17-year-olds as it …

Source: Philippine Daily Inquirer February 01, 2022 09:59 UTC